I-Evolocumab - Ukusetyenziswa, Idosi, Iziphumo Ezingalindelekanga kunye nokunye

Intshayelelo: Yintoni i-Evolocumab?

I-Evolocumab liyeza elisetyenziselwa ukwehlisa amanqanaba e-cholesterol egazini. Yeyodidi lwamachiza aziwa ngokuba zii-PCSK9 inhibitors. Ngokujolisa kwiprotheyini ethile esibindini, i-Evolocumab inceda ekunciphiseni i-low-density lipoprotein (LDL) cholesterol, edla ngokubizwa ngokuba yi-cholesterol "embi". Eli liyeza liluncedo kakhulu kubantu abanamanqanaba aphezulu e-cholesterol angalawulwa ngokwaneleyo ngonyango lwe-statin yesintu.

Ukusetyenziswa kwe-Evolocumab

I-Evolocumab ivunyiwe kusetyenziso oluninzi lwezonyango, kubandakanya:

• I-Hyperlipidemia yokuqala: Isetyenziselwa ukunyanga abantu abadala abane-primary hyperlipidemia (kuquka ne-heterozygous familial hypercholesterolemia) ukunciphisa i-LDL cholesterol.
• IFamily Hypercholesterolemia: Le meko yemfuza ikhokelela kumanqanaba aphezulu kakhulu e-cholesterol. I-Evolocumab iyasebenza ekulawuleni le meko.
• Ukunciphisa uMngcipheko weCardiovascular: I-Evolocumab imiselwe ukunciphisa umngcipheko wokuhlaselwa yintliziyo kunye ne-stroke kwizigulane ezine-cardiovascular disease.
• Ukudibanisa Unyango: Ingasetyenziselwa kunye namanye amayeza okunciphisa i-cholesterol, njenge-statins, ukuphucula ukusebenza kakuhle.

Ingaba isebenza kanjani

I-Evolocumab isebenza ngokuthintela iprotheni ye-PCSK9, edlala indima ebalulekileyo kwimetabolism ye-cholesterol. Ngamagama alula, i-PCSK9 ibophelela kwi-LDL receptors kwiiseli zesibindi, ezikhokelela ekuthotyweni kwazo. Ezi zamkeli zinoxanduva lokususa i-cholesterol ye-LDL egazini. Ngokuvala i-PCSK9, i-Evolocumab ikwandisa inani le-LDL receptors ezikhoyo, ivumela isibindi ukuba sisuse i-cholesterol ye-LDL eninzi egazini, ngaloo ndlela inciphisa amanqanaba e-cholesterol.

Isisombululo kunye noLawulo

I-Evolocumab ilawulwa ngenaliti. Idosi eqhelekileyo kubantu abadala idla ngokuba yi-140 mg rhoqo kwiiveki ezimbini okanye i-420 mg kanye ngenyanga. Kwizigulane zabantwana abaneminyaka eyi-12 ubudala nangaphezulu abane-heterozygous family hypercholesterolemia, idosi inokwahluka ngokusekelwe kubunzima. Kubalulekile ukulandela imiyalelo yomboneleli wezempilo malunga nokuphindaphindwa kunye nendlela yolawulo.

Iziphumo ezisecaleni ze-Evolocumab

Njengawo onke amayeza, i-Evolocumab inokubangela iziphumo ebezingalindelekanga. Iziphumo ebezingalindelekanga eziqhelekileyo ziquka:

• Ukusabela kwendawo yokutofa (intlungu, ububomvu, ukudumba)
• Ubuhlungu besisu
• Ukukhathala
• intloko ebuhlungu

Iziphumo ezibi kakhulu, nangona zingaxhaphakanga kangako, zinokubandakanya:

• Ukwaliwa (irhashalala, ukurhawuzelelwa, ukudumba)

Izigulana kufuneka zixele naziphi na iimpawu ezingaqhelekanga kumboneleli wabo wezempilo ngokukhawuleza.

Ukusebenzisana kweziyobisi

I-Evolocumab inesakhono esisezantsi sokusebenzisana kweziyobisi. Nangona kunjalo, kubalulekile ukwazisa umboneleli wakho wezempilo malunga nawo onke amayeza owathathayo, kubandakanywa:

• Iistatins (umz., i-atorvastatin, i-simvastatin)
• Amanye amayeza okunciphisa i-cholesterol

Olu lwazi lunceda ukuqinisekisa unyango olukhuselekileyo nolusebenzayo.

Iinzuzo ze-Evolocumab

I-Evolocumab ibonelela ngeengenelo ezininzi zeklinikhi kunye nezisebenzayo:

• UkuNcitshiswa kwe-LDL okuBalulekileyo: Inokwehlisa amanqanaba e-cholesterol ye-LDL ukuya kuthi ga kwi-60% xa isetyenziswa yodwa okanye idityaniswe nolunye unyango.
• Ukhuseleko lwentliziyo: Yehlisa umngcipheko wokuhlaselwa yintliziyo kunye ne-stroke kwizigulana ezisengozini enkulu.
• Ulawulo olululo: Isitofu sinokuzinikezela ngokwaso, nto leyo eyenza kube lula kwizigulane ukulawula unyango lwazo.
• Inyamezeleke: Izigulana ezininzi ziyinyamezela kakuhle i-Evolocumab, eneziphumo ebezingalindelekanga ezilawulekayo.

Ukuchasana kwe-Evolocumab

I-Evolocumab kufuneka iphetshwe kwiimeko ezithile, kubandakanywa:

• Ukukhulelwa: Iimpembelelo ekukhuleni komntwana azifundanga kakuhle.
• Isifo sesibindi esinzima: Idatha encinci iyafumaneka kwizigulane ezinengxaki enkulu yesibindi; ukusetyenziswa kwayo kufuneka kusekelwe kugwebo lwezonyango.
• Iintshukumo Zokwalana Nezinto: Abantu abane-hypersensitivity eyaziwayo kwi-Evolocumab okanye nawaphi na amalungu ayo kufuneka bayiphephe.

Izilumkiso kunye nezilumkiso

Ngaphambi kokuqala i-Evolocumab, abaguli kufuneka baxoxe ngembali yabo yezonyango kunye nomboneleli wabo wezempilo. Izilumkiso ezibalulekileyo ziquka:

• Iimvavanyo zokuSebenza kwesibindi: Ukuhlolwa rhoqo kwee-enzyme zesibindi akufuneki ngaphandle kokuba kubonisiwe ngokwezonyango.
• Umzimba: Yazisa ugqirha wakho malunga nayo nayiphi na i-allergies kumayeza okanye izinto.

FAQs

• Isetyenziselwa ntoni i-Evolocumab? I-Evolocumab isetyenziselwa ukunciphisa amanqanaba e-cholesterol ye-LDL kwizigulane ezine-cholesterol ephezulu, kubandakanywa nezo zine-hypercholesterolemia yosapho.
• Ilawulwa njani i-Evolocumab? I-Evolocumab inikwa njengenaliti, qho kwiiveki ezimbini okanye kanye ngenyanga, kuxhomekeke kwidosi emiselweyo.
• Zeziphi iziphumo ebezingalindelekanga eziqhelekileyo? Iziphumo ebezingalindelekanga eziqhelekileyo zibandakanya ukusabela kwendawo yokutofa, iintlungu zemisipha, ukudinwa, kunye nentloko.
• Ndingayithatha i-Evolocumab ngeestatins? Ewe, i-Evolocumab ingasetyenziswa ngokudityaniswa nama-statins kulawulo olungcono lwe-cholesterol.
• Ngaba i-Evolocumab ikhuselekile ngexesha lokukhulelwa? I-Evolocumab ayikhuthazwa ngexesha lokukhulelwa ngenxa yedatha engonelanga yokhuseleko.
• Isebenza njani i-Evolocumab? Isebenza ngokuvimbela iprotheni ye-PCSK9, ukwandisa inani le-LDL receptors kwisibindi, esinceda ukunciphisa i-LDL ye-cholesterol.
• Ndingenza ntoni xa ndiphosa ithamo? Ukuba uphose ithamo, yithathe ngokukhawuleza xa ukhumbula. Ukuba isondele kwidosi yakho elandelayo ecwangcisiweyo, tsiba idosi oyiphosileyo kwaye uqhubeke neshedyuli yakho yesiqhelo.
• Ngaba kukho nayiphi na imiphumo emibi? Iziphumo ebezingalindelekanga ezimandundu zinokubandakanya ukuchasana nokwaliwa kunye nokungahambi kakuhle kwe-enzyme yesibindi. Qhagamshelana nogqirha wakho ukuba ufumana iimpawu ezinzima.
• Kukangaphi kufuneka ndibonane nogqirha wam ngelixa ndikwi-Evolocumab? Kufuneka ukudibana rhoqo nogqirha ukuze kujongwe amanqanaba e-cholesterol kunye nempendulo yonyango iyonke.
• Ndingayeka ukuthatha i-Evolocumab ukuba amanqanaba e-cholesterol yam ayaphucuka? Sukuyeka ukuthatha i-Evolocumab ngaphandle kokubonisana nomboneleli wakho wezempilo, njengoko amanqanaba e-cholesterol anokuphakama kwakhona.

Amagama eBrand

I-Evolocumab ithengiswa phantsi kwamagama amaninzi, kuquka:

• Repatha

isiphelo

I-Evolocumab sisixhobo esinamandla sokulwa ne-cholesterol ephezulu kunye nesifo senhliziyo. Ukukwazi ukuthoba kakhulu amanqanaba e-cholesterol e-LDL kwenza ukuba ibe lukhetho oluyimfuneko kwizigulana ezisokolayo ukulawula i-cholesterol yazo ngokutya kunye namayeza esintu. Ngolawulo lwayo olufanelekileyo kunye neprofayili yokhuseleko olufanelekileyo, i-Evolocumab idlala indima ebalulekileyo ekuphuculeni impilo yentliziyo kunye nokunciphisa umngcipheko weziganeko ezinzulu zentliziyo.